title: Evaluation of adverse experiences related to pamidronate infusion in Paget's disease of bone.
authors.forename: H M
authors.initials: HM
authors.lastname: Buckler
authors.forename: S J
authors.initials: SJ
authors.lastname: Mercer
authors.forename: C E
authors.initials: CE
authors.lastname: Davison
authors.forename: S
authors.initials: S
authors.lastname: Hollis
authors.forename: P C
authors.initials: PC
authors.lastname: Richardson
authors.forename: D G
authors.initials: DG
authors.lastname: Anderson
mesh_terms: D000368:Aged; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000009:adverse effects*; D004311:Double-Blind Method; D005260:Female; D005334:Fever / Q000139:chemically induced; D006261:Headache / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D010001:Osteitis Deformans / Q000188:drug therapy*; D000077268:Pamidronate
chemical_list: D000893:Anti-Inflammatory Agents; D004164:Diphosphonates; D000077268:Pamidronate